Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

195.93 +0.68 (+0.35%)
Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
News headline image
Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Dow Health Giant J&J Surges After Hiking Outlook On Strong Quarterly Report ↗
The company also easily beat second-quarter adjusted earnings and sales forecasts. 
Via Investor's Business Daily
Topics Stocks
News headline image
Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance ↗
Johnson & Johnson beat Q2 estimates and raised its 2025 outlook, driven by strong cancer and MedTech sales despite Stelara declines. 
Via Benzinga
News headline image
Johnson & Johnson (NYSE:JNJ) Reports Bullish Q2, Full-Year Sales Guidance is Optimistic
Multinational healthcare company Johnson & Johnson (NYSE:JNJ) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 5.8% year on year to $23.74 billion. The company’s full-year revenue... 
Via StockStory
Johnson & Johnson Reportedly Halves Its Forecast Of US Tariff Impact To $200M, Sparks Retail Chatter ↗
Via Stocktwits
News headline image
What's Next: Johnson & Johnson's Earnings Preview ↗
 
Via Benzinga
News headline image
P/E Ratio Insights for Johnson & Johnson ↗
 
Via Benzinga
News headline image
Johnson & Johnson Outperforms Q2 Expectations; Provides Positive Outlook ↗
Johnson & Johnson surpassed expectations in Q2 2025 with a notable increase in earnings per share and revenue. 
Via Talk Markets
Dow Futures Edge Up Even As Investors Maintain Caution: ASML, UAL, JNJ, BAC, GS Among Stocks To Watch ↗
Via Stocktwits
Topics Stocks
News headline image
3 Magnificent S&P 500 Dividend Stocks Down 16% to 20% to Buy and Hold Forever ↗
Via The Motley Fool
Topics Stocks
News headline image
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook
From Johnson & Johnson
Via Business Wire
News headline image
Earnings Scheduled For July 16, 2025 ↗
 
Via Benzinga
News headline image
10 Dividend Stocks to Double Up On Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock. ↗
Via The Motley Fool
Topics Retirement
News headline image
Should You Buy Johnson & Johnson Stock Before July 16th? ↗
Via The Motley Fool
Topics Government World Trade
News headline image
These 3 Undervalued Stocks Could Surge as Value Rotation Nears ↗
A rotation back into value stocks may be imminent in today's market, giving investors a chance to expose themselves into a catch up play. 
Via MarketBeat
Topics ETFs Economy
News headline image
Andrew Hill Dumps 38,000 Johnson & Johnson Shares in Q2 2025 Exit ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Kenvue CEO Thibaut Mongon Steps Down, Director Kirk Perry To Take On Interim CEO Role ↗
Perry has previously worked with Circana, Google, and was with Procter and Gamble for 23 years. 
Via Stocktwits
Topics Government Stocks
News headline image
This Stock Has Increased 4,720%: Here's Why It's Still a Buy ↗
Via The Motley Fool
News headline image
5 of the Best Stocks to Buy in July ↗
These stocks are ready to pop higher. 
Via The Motley Fool
News headline image
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest. 
Via Benzinga
Topics Government World Trade
News headline image
The Best High Yield Medical Device Stock to Invest $1,000 in Right Now ↗
Via The Motley Fool
News headline image
What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill ↗
A steady dose of quality companies will keep your portfolio growing big and strong. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Johnson & Johnson Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗
 
Via Benzinga
News headline image
2 Dividend Stocks to Double Up on Right Now ↗
Via The Motley Fool
News headline image
Forecasting The Future: 8 Analyst Projections For Johnson & Johnson ↗
 
Via Benzinga
News headline image
Option Wheel Strategy: How to Earn Monthly Income Trading Options
The search for consistent, predictable income is a constant for investors in both bull and bear markets. While traditional dividend stocks and bonds are reliable tools, a lesser-known but increasingly... 
Via MarketMinute
Topics Bonds Retirement
News headline image
Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity ↗
Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal. 
Via Investor's Business Daily
Topics Intellectual Property
News headline image
Johnson & Johnson's Outlook Clouded By $2 Billion Headwind ↗
Johnson & Johnson's 2025 outlook sees slight EPS and revenue upgrades, while headwinds from biosimilars and tariffs are expected to weigh on performance. 
Via Benzinga
Topics World Trade
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.